Neoplasms of the parathyroid glands are uncommon in all species of laboratory and domestic animals, but occur in low incidence in rats, Syrian hamsters, and dogs and rarely in mice. Proliferative lesions of the parathyroid gland include hyperplasia (diffuse and focal), adenomas, and carcinomas. The tumors may be functional or nonfunctional. Trophic atrophy of remaining parathyroid tissue is present around functional tumors. Humoral hypercalcemia of malignancy (HHM) is a syndrome that occurs in human and animal patients with certain malignant neoplasms and is characterized by hypercalcemia, hypophosphatemia, and increased osteoclastic bone resorption. The syndrome is thought to be due to the release of parathyroid hormone (PTH)-like factors by the tumor cells which bind to PTH receptors in bone and kidney and result in the clinical manifestations of HHM. Parathyroid hormone-related protein (PTHrP) is a newly purified and sequenced protein which originated from human tumors associated with HHM. PTHrP has been shown to stimulate in vitro and in vivo effects similar to PTH-like proteins isolated from tumors associated with HHM. Well characterized animal models of HHM include a rat Leydig cell tumor line (Rice-500), the rat Walker mammary carcinosarcoma, and the canine apocrine adenocarcinoma. All 3 models have been found to contain 3 biologic activities which are thought to be important in the pathogenesis of HHM, viz., in vitro bone resorbing activity, adenylate cyclase-stimulating activity of bone and kidney cells, and transforming growth factor activity. The first 2 activities are due to PTH-like proteins which are able to compete for binding to the PTH receptor. The complete spectrum of functional disturbances in patients with HHM may be the result of the combined effects of a PTH-like protein (i.e., PTHrP) and transforming growth factors.
1. Arnold A, Staunton CE, Kim HG, Gaz RD, and Kronenberg HM (1988). Monoclonality and abnormal parathyroid hormone genes in parathyroid adenomas.N. Engl. J. Med.318: 658–662.
2.
2. Brandi ML, Aurbach GD, Fitzpatrick LA, Quarto R, Spiegel AM, Bliziotes MM, Norton JA, Doppman JL, and Marx SJ (1986). Parathyroid mitogenic activity in plasma from patients with familial mutliple endocrine neoplasia type I.N. Engl. J. Med.314: 1287–1292.
3.
3. Broadus AE, Mangin M, Insogna KL, Weir EC, Burtis WJ, and Stewart AF (1988). Humoral hypercalcemia of malignancy. Identification of a novel parathyroid hormone-like peptide.N. Engl. J. Med.319: 556–563.
4.
4. Brown EM and LeBoff MS (1986). Pathophysiology of hyperparathyroidism.Prog. Surg.18: 13–22.
5.
5. Burtis WJ, Wu T, Bunch C, Wysolmerski JJ, Insogna KL, Weir EC, Broadus AE, and Stewart AF (1987). Identification of a novel 17,000-dalton parathyroid hormone-like adenylate cyclase-stimulating protein from a tumor associated with humoral hypercalcemia of malignancy.Biol. Chem.262: 7151–7156.
6.
6. Capen CC (1978). Tumors of the endocrine glands. In: Tumors in Domestic Animals, 2nd ed., JE Moulton (ed). University of California Press, Berkeley and Los Angeles, pp. 372–429.
7.
7. Capen CC (1985). The endocrine glands. In: Pathology of Domestic Animals, 3rd ed., KVF Jubb, PC Kennedy, and N Palmer (eds). Academic Press, Inc., Orlando, pp. 238–305.
8.
8. Capen CC (1988). Endocrine system. In: Special Veterinary Pathology, RG Thompson (ed). B. C. Decker, Inc., Philadelphia, pp. 369–436.
9.
9. Capen CC (1983). Structural and biochemical aspects of parathyroid gland function in animals. In: Endocrine System, TC Jones, U Mohr, and RD Hunt, (eds). Springer-Verlag, Berlin, pp. 217–247.
10.
10. Capen CC (1989). Neoplasms of the parathyroid glands. In: Atlas of Tumor Pathology in the F344 Rat, SF Stinson and G Reznik (eds). CRC Press, Inc., Boca Raton, FL (in press).
11.
11. Danks JA, Ebeling PR, Rodda CP, Hayman J, Chou ST, Moseley JM, Dunlop JM, Demp BE, and Martin TJ (1988). Immunohistochemical localization of parathyroid hormone-related protein of cancer.J. Bone Min. Res.3: S214.
12.
12. Dewhirst FE, Ago JM, Peros WJ, and Stashenko P (1987). Synergism between parathyroid hormone and interleukin-1 in stimulating bone resorption in organ culture.J. Bone Min. Res.2: 127–134.
13.
13. Goustin AS, Leof EB, Shipley GD, and Moses HL (1986). Growth factors and cancer.Cancer Res.46: 1015–1029.
14.
14. Holick MF, Nussbaum S, and Persons KS (1988). PTH-like humoral hypercalcemia factor (HHF) of malignancy may be an epidermal differentiation factor: Synthetic hHHF (1–34) amide inhibits terminal differentiation of cultured human keratinocytes.J. Bone Min. Res.3: S214.
15.
15. Horiuchi N, Caulfield MP, Fisher JE, Goldman ME, McKee RL, Reagan JE, Levy JJ, Nutt RF, Rodan SB, Schofield TL, Clemens TL, and Rosenblatt M (1987). Similarity of synthetic peptide from human tumor to parathyroid hormone in vivo andin vitro. Science238: 1566–1568.
16.
16. Ibbotson KJ, D'Souza SM, Smith DD, Carpenter G, and Mundy GR (1985). EGF receptor antiserum inhibits bone resorbing activity produced by a rat Leydig cell tumor associated with the humoral hypercalcemia of malignancy.Endocrinology116: 469–471.
17.
17. Ikeda K, Mangin M, Dreyer BE, Webb AC, Posillico JT, Stewart AF, Bander NH, Weir EC, Insogna KL, and Broadus AE (1988). Identification of transcripts encoding a parathyroid hormone-like peptide in messenger RNAs from a variety of human and animal tumors associated with humoral hypercalcemia of malignancy.J. Clin. Invest.81: 2010–2014.
18.
18. Ikeda K, Weir E, Mangin M, Brown E, and Broadus A (1988). Tissue-specific and developmental expression of mRNAs encoding a PTH-like peptide.J. Bone Min. Res.3: S213.
19.
19. Insogna KL, Burtis WJ, Morris CA, Brady TG, and Weir EC (1988). Isolation of 16,000 dalton PTH-like proteins from two animal tumors causing humoral hypercalcemia of malignancy.J. Bone Min. Res.3: S70.
20.
20. Insogna KL, Weir EC, Wu TL, Stewart AF, Broadus AE, Burtis WJ, and Centrella M (1987). Co-purification of transforming growth factor beta-like activity with PTH-like and bone-resorbing activities from a tumor associated with humoral hypercalcemia of malignancy.Endocrinology120: 2183–2185.
21.
21. Kemp BE, Moseley JM, Rodda CP, Ebeling PR, Wettenhall REH, Stapleton D, Diefenbach-Jagger H, Ure F, Michelangeli VP, Simmons HA, Raisz LG, and Martin TJ (1987). Parathyroid hormone-related protein of malignancy: Active synthetic fragments.Science238: 1568–1570.
22.
22. Lewis DJ and Cherry CP (1982). Parathyroid adenoma in mice: A report of two cases.J. Comp. Path.92: 337–339.
23.
23. Mangin M, Webb AC, Dreyer BE, Posillico JT, Ikeda K, Weir EC, Stewart AF, Bander NH, Milstone L, Barton DE, Francke U, and Broadus AE (1988). Identification of a cDNA encoding a parathyroid hormone-like peptide from a human tumor associated with humoral hypercalcemia of malignancy.Proc. Natl. Acad. Sci. USA85: 597–601.
24.
24. Merryman JI, Rosol TJ, and Capen CC (1989). Identification and separation of PTH-like activities and transforming growth factor-α and -β in the canine adenocarcinoma (CAC-8) model of humoral hypercalcemia of malignancy.Endocrinology124: 2456–2463.
25.
25. Meuten DJ, Cooper BJ, Capen CC, Chew DJ, and Kociba GJ (1981). Hypercalcemia associated with an adenocarcinoma derived from the apocrine glands of the anal sac.Vet. Pathol.18: 454–471.
26.
26. Meuten DJ, Segre GV, Capen CC, Kociba GJ, Voekel EF, Levine L, Tashjian AH, Chew DJ, and Nagode LA (1983). Hypercalcemia in dogs with adenocarcinoma derived from apocrine glands of the anal sac: Biochemical and histomorphometric investigations.Lab. Invest.48: 428–435.
27.
27. Moseley JM, Kubota M, Diefenbach-Jagger H, Wettenhall REH, Kemp BE, Suva LJ, Rodda CP, Ebeling PR, Hudson PJ, Zajac JD, and Martin TJ (1987). Parathyroid hormone-related protein purified from a human lung cancer cell line.Proc. Natl. Acad. Sci. USA84: 5048–5052.
28.
28. Motokura T, Fukumoto S, Takahashi S, Watanabe T, Matsumoto T, Igarashi T, and Ogata E (1988). Expression of parathyroid hormone-related protein in a human T-cell lymphotropic virus type 1-infected cell line.Biochem. Biophys. Res. Commun.154: 1182–1188.
29.
29. Mundy GR (1988). Hypercalcemia of malignancy revisited.J. Clin. Invest.82: 1–6.
30.
30. Mundy GR, Ibbotson KJ, and D'Souza SM (1985). Tumor products and the hypercalcemia of malignancy.J. Clin. Invest.394: 391–394.
31.
31. Mundy GR, Ibbotson KJ, D'Souza SM, Simpson EL, Jacobs JW, and Martin TJ (1984). The hypercalcemia of cancer. Clinical implications and pathogenic mechanisms.N. Engl. J. Med.310: 1718–1727.
32.
32. Rodda CP, Kubota M, Heath JA, Ebeling PR, Moseley JM, Care AD, Caple IW, and Martin TJ (1988). Evidence for a novel parathyroid hormone-related protein in fetal lamb parathyroid glands and sheep placenta: Comparisons with a similar protein implicated in humoral hypercalcemia of malignancy.J. Endocrinol.117: 261–271.
33.
33. Rosol TJ and Capen CC (1988). Pathogenesis of humoral hypercalcemia of malignancy.Domes. An. Endocrinol.5: 1–21.
34.
34. Rosol TJ and Capen CC (1988). Inhibition of in vitro bone resorption by a parathyroid hormone receptor antagonist in the canine adenocarcinoma model of humoral hypercalcemia of malignancy.Endocrinology122: 2098–2102.
35.
35. Rosol TJ and Capen CC (1989). Effects of infusion of human parathyroid hormone-related protein (1–40) in nude mice. Histomorphometric and biochemical investigations.J. Bone Min. Res.3: 699–706.
36.
36. Rosol TJ, Capen CC, Martin TJ, Hayman J, Ebeling PR, and Danks JA (1988). Immunohistochemical staining for human parathyroid hormone-related protein in canine adenocarcinoma tumor line (CAC-8) that induces humoral hypercalcemia of malignancy in nude mice.J. Bone Min. Res.3: S105.
37.
37. Rosol TJ, Capen CC, Weisbrode SE, and Horst RL (1986). Humoral hypercalcemia of malignancy in nude mouse model of a canine adenocarcinoma derived from apocrine glands of the anal sac.Lab. Invest.54: 679–688.
38.
38. Rosol TJ, Chew DJ, Capen CC, and Sherding RG (1988). Acute hypocalcemia associated with infarction of parathyroid gland adenomas in two dogs.J. Am. Vet. Med. Assoc.192: 212–214.
39.
39. Sartori L, Weir EC, Stewart AF, Broadus AE, Mangin M, Barrett PQ, and Insogna KL (1988). Synthetic and partially-purified adenylate cyclase-stimulating proteins from tumors associated with humoral hypercalcemia of malignancy inhibit phosphate transport in a PTH-responsive renal cell line.J. Clin. Endocrinol. Metab.66: 459–461.
40.
40. Sato K, Fujii Y, Ono M, Nomura H, and Shizume K (1987). Production of interleukin 1 alpha-like factor and colony-stimulating factor by a squamous cell carcinoma of the thyroid (T3M-5) derived from a patient with hypercalcemia and leukocytosis.Cancer Res.47: 6474–6480.
41.
41. Simpson EL, Mundy GR, D'Souza SM, Ibbotson KJ, Bockman R, and Jacobs JW (1983). Absence of parathyroid hormone messenger RNA in nonparathyroid tumors associated with hypercalcemia.N. Engl. J. Med.309: 325–330.
42.
42. Stewart AF, Horst R, Deftos LJ, Cadman EC, Lang R, and Broadus AE (1980). Biochemical evaluation of patients with cancer-associated hypercalcemia: Evidence for humoral and nonhumoral groups.N. Engl. J. Med.303: 1377–1383.
43.
43. Stewart AF, Mangin M, Wu T, Goumas D, Insogna KL, Burtis WJ, and Broadus AE (1988). Synthetic human parathyroid hormone-like protein stimulates bone resorption and causes hypercalcemia in rats.J. Clin. Invest.81: 596–600.
44.
44. Strewler GJ, Stern PH, Jacobs JW, Eveloff J, Klein RF, Leung SC, Rosenblatt M, and Nissenson RA (1987). Parathyroid hormonelike protein from human renal carcinoma cells. Structural and functional homology with parathyroid hormone.J. Clin. Invest.80: 1803–1807.
45.
45. Suva LJ, Winslow GA, Wettenhall REH, Hammonds RG, Moseley JM, Diefenbach-Jagger H, Rodda CP, Kemp BE, Rodriguez H, Chen EY, Hudson PJ, Martin TJ, and Wood WI (1987). A parathyroid hormone-related protein implicated in malignant hypercalcemia: Cloning and expression.Science237: 893–896.
46.
46. Thompson DD, Seedor JG, Fisher JE, Rosenblatt M, and Rodan GA (1988). Direct action of the parathyroid hormone-like human hypercalcemic factor on bone.Proc. Natl. Acad. Sci. USA85: 5673–5677.
47.
47. Weir E, Greenlee P, Matus R, Brooks M, Morris C, and Insogna K (1988). Hypercalcemia in canine lymphosarcoma is associated with the T-cell sub-type and with secretion of the PTH-like factor.J. Bone Min. Res.3: S106.
48.
48. Yates AJP, Gutierrez GE, Smolens P, Travis PS, Katz MS, Aufdemorte TB, Boyce BF, Hymer TK, Poser JW, and Mundy GR (1988). Effects of a synthetic peptide of a parathyroid hormone-related protein on calcium homeostasis, renal tubular calcium reabsorption, and bone metabolism in vivo and in vitro in rodents.J. Clin. Invest.81: 932–938.
